ZBiotics is a synthetic biology company that specializes in bioengineering probiotic bacteria for nutraceutical and consumer health applications. Founded in 2016 and headquartered in San Francisco, the company focuses on creating functional probiotics with specific metabolic capabilities. Their first commercial product, launched in 2019, is the world's first genetically engineered probiotic designed to break down a toxic byproduct of alcohol.
ZBiotics was founded in 2016 by the ZBiotics Team. The company is currently headquartered in San Francisco, California, and operates with a full-time, remote-friendly commitment structure. They are recognized for their work in the Y Combinator accelerator program.
ZBiotics is a leading company in the consumer-facing synthetic biology space, specifically known for its work in the nutraceutical sector. It distinguished itself in 2019 by launching the first-ever genetically engineered probiotic available to the public. The company is actively developing a broader pipeline of engineered probiotics to address various consumer health needs beyond their initial product.
ZBiotics developed a specific genetically engineered probiotic to help solve the problem of alcohol byproduct buildup. This bioengineered bacterium is designed to break down the toxic byproducts that accumulate during alcohol consumption. It represents the company's first application of synthetic biology in the food and beverage and health and wellness markets.
ZBiotics is headquartered in San Francisco, California. The company was founded there in 2016 and maintains a remote-friendly work environment for its full-time team. Their operations are centered around the development of synthetic biology solutions for the global health and wellness market.